← Back to Clinical Trials
Recruiting NCT06434870

Effect of Spinal Anesthesia in Elective Cesarean Cases on Frontal QRS Angle in Anemic and Non-Anemic Patients

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Pregnancy Anemia
Sponsor Sanliurfa Mehmet Akif Inan Education and Research Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex FEMALE
Min Age 18 Years
Max Age 45 Years
Start Date 2024-04-20
Completion 2024-08-31

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The QRS-T angle represents a novel marker of myocardial repolarisation. It is defined as the angle difference between the direction of ventricular depolarisation (QRS wave) and the direction of ventricular repolarisation (T wave). It is an indicator of instability in the electrophysiological properties of the myocardium and is associated with arrhythmias. The frontal QRS-T angle is a straightforward, cost-effective parameter that can be readily obtained from 12-lead electrocardiography. The most prevalent arrhythmias during pregnancy are atrial arrhythmias. However, ventricular tachyarrhythmias are exceedingly rare during pregnancy and may be life-threatening. Caesarean section is one of the most common surgical procedures. General anaesthesia, spinal anaesthesia and epidural anaesthesia can be employed in these patients. Spinal anaesthesia is a frequently employed method in caesarean section operations due to its rapid onset of effect, technical simplicity of application and higher probability of success. In pregnant women, anaemia is defined as a haemoglobin concentration below 11 mg/dL in the first trimester, 11 mg/dL in the second trimester and 10.5 mg/dL in the third trimester.

Eligibility Criteria

Inclusion Criteria: * Aged 18-45 years * Patients with American Society of Anesthesiologists (ASA) II classification Exclusion Criteria: * Patients with rhythm disorders * Patients with electrolyte disturbances * Patients with liver and/or renal failure * Obese patients (body mass index \> 30) * Trauma patients * Cancer patients * ASA III-IV patients * Patients who do not wish to participate in the study will be excluded.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}